Maia Biotechnology Inc

MAIA
3,28
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 11:50:16
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202414:08BWMAIA Biotechnology Announces Share Purchase by Director..
29/4/202414:08BWMAIA Biotechnology Announces Share Purchase by Director Stan..
23/4/202414:51BWMAIA Biotechnology Announces $1.00 Million Private Placement
05/4/202414:01BWMAIA Biotechnology to Present at Two Investor Conferences in..
28/3/202420:00BWMAIA Biotechnology Announces Share Purchases by Directors..
26/3/202420:00BWMAIA Biotechnology Announces Share Purchase by Director..
26/3/202413:01BWMAIA Biotechnology Announces $1.33 Million Private Placement
22/3/202420:00BWMAIA Biotechnology Announces Share Purchase by Director Stan..
21/3/202420:00BWMAIA Biotechnology Welcomes Prominent Medical Oncology..
08/3/202422:15EDGAR2Form 8-K - Current report
07/3/202415:45BWMAIA Biotechnology to Participate in the 36th Annual ROTH..
06/3/202417:04BWMAIA Biotechnology and Nationwide Children’s Hospital..
06/3/202414:48BWMAIA Biotechnology Announces Strong Efficacy of THIO as..
06/3/202414:00EDGAR2Form 8-K - Current report
05/3/202414:45BWMAIA Biotechnology CEO Details Immuno-Oncology Cancer..
27/2/202423:23EDGAR2Form 8-K - Current report
23/2/202422:17EDGAR2Form 8-K - Current report
14/2/202423:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202423:15EDGAR2Form 8-K - Current report
07/2/202414:01BWMAIA Biotechnology Announces Publication in Nature..
30/1/202415:00EDGAR2Form 8-K - Current report
26/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202413:15BWMAIA Biotechnology Announces Publication of International..
20/1/202403:00EDGAR2Form 144 - Report of proposed sale of securities
18/1/202412:01EDGAR2Form 8-K - Current report
17/1/202415:00BWMAIA Biotechnology Provides Positive Phase 2 Clinical..
05/1/202414:00BWMAIA Biotechnology to Present at Biotech Showcase 2024 on..
04/1/202403:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202402:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202313:00EDGAR2Form 8-K - Current report
19/12/202313:00BWMAIA Biotechnology Announces Dose Selection in THIO-101..
29/11/202322:19EDGAR2Form D - Notice of Exempt Offering of Securities
17/11/202321:52BWMAIA Biotechnology Announces Closing of $4 Million..
17/11/202315:09EDGAR2Form 8-K - Current report
17/11/202315:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/11/202323:26EDGAR2Form 8-K - Current report
15/11/202315:35BWMAIA Biotechnology Announces $4 Million Registered Direct..
15/11/202314:42EDGAR2Form 8-K - Current report
15/11/202314:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/11/202312:07EDGAR2Form 8-K - Current report
10/11/202313:01BWFDA Grants Orphan Drug Designation to MAIA Biotechnology for..
07/11/202314:15BWMAIA Biotechnology Reports Third Quarter 2023 Financial..
07/11/202314:05EDGAR2Form 8-K - Current report
07/11/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202322:24EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 3,28

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network